Current Trends In The Laboratory Diagnosis Of Tuberculosis by Ogbaini-Emovon, E
 
 
 79  
 
CURRENT TRENDS IN THE LABORATORY DIAGNOSIS OF TUBERCULOSIS  
 
*E. Ogbaini-Emovon  
 




Dr E. Ogbaini-Emovon   
Department of Medical Microbiology 
University of Benin Teaching Hospital,  




Mycobacterium tuberculosis (M. 
tuberculosis) causes tuberculosis and 
is a very important pathogen of 
humans. Tuberculosis kills more 
people than ever, with the increasing 
number of HIV-infected individuals1.  
The fact sheet of global tuberculosis is 
stunning with one third of the world’s 
population currently infected and new 
infections occur every second, 
resulting in new tuberculosis infection 
in 1% of the world population 
annually2. It is projected that newly 
acquired infections between 2002 and 
2010 would be 1 billion persons, of 
these, 150 million will get sick and 36 
million will die of tuberculosis2. In Sub-
Sahara African countries, the 
incidence of tuberculosis has doubled 
since the early 1980s3. 
 Mycobacterium tuberculosis is related 
and associated with other species of 
mycobacteria, referred to as the 
Mycobacteria Tuberculosis Complex 
(MTB complex). MTB complex 
includes; M. bovis, (including the 
vaccination strain BCG) M. 
tuberculosis, M. africanum, M. microti, 
and M. canettii4.These grouping is 
based on several parameters which 
include the analysis of antigenic 
extracts, target epitopes for 
monoclonal antibodies and antigenic 
and DNA relatedness5. 
Historically, the diagnosis and 
treatment of M. tuberculosis has been 
difficult, because of its peculiarities; it 
has a high concentration of lipids in the 
cell wall, which makes it impermeable 
to stains and dyes, requiring special 
staining techniques for microscopic 
observation, resistant to many 
antibiotics, resistant to osmotic lysis 
via complement deposition, as well as 
resistant to lethal oxidation and 
survival inside macrophages, making it 
possible to undergo a long period of 
latency. Unlike many pathogenic 
bacteria, M. tuberculosis also grows 
slowly, making culture and 
susceptibility testing time consuming. 
This write- up examines the critical role 
of the clinical microbiology laboratory, 
through the various modalities of 
laboratory diagnosis ,strain-typing and 
susceptibility testing, with emphasis on 
the advantages and drawback of these 
techniques.  
 
ROLE OF THE MEDICAL 
MICROBIOLOGY LABORATORY
    
The laboratory physicians have been 
on the front line in the fight against 
tuberculosis (TB) ever since Dr Robert 
Koch announce his discovering of the 
tuberculus bacillus in 1882. Driven by 
the worldwide increase in the 
incidence of tuberculosis, several 
changes in laboratory practice have 
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evolved over the past several years. 
The challenge for the clinical 
laboratory is to provide the most rapid 
and reliable technologies for diagnosis 
and antimycobacterial drug 
susceptibility, as well as speciation 
and strain- typing, possibly within days 
or even hours rather than weeks. 
 





4) Molecular Techniques 
 
CLINICAL SPECIMENS 
This depends on the clinical 
presentation and may include any 
body fluid or tissue6 
 
1) Pulmonary  Tuberculosis 
  
This is the commonest form of 
tuberculosis and various respiratory 
specimens may be useful, including ; 
spontaneously expectorated sputum, 
normal – saline nebulize induced 
sputum transtracheal aspirate, 
bronchoalveolar lavage, 
bronchoalveolar brushing etc. 
 
2) Extra pulmonary 
Tuberculosis 
This may affect various organs of the 
body and as such the following body 
fluids and tissues may be useful 
depending on clinical presentation.; 
pleural fluid ,pericardial fluid, 
peritoneal fluid, urine, joint aspirate, 
gastric aspirate, CSF, pus, blood , 
bone marrow biopsy or aspirate, lymph 
node, skin and bone. 
 




Three specimen of sputum are 
required in 2 visits for two days; Spot – 
Morning –Spot. However, for patients 
on admission, the specimens can 
conveniently be collected for three 
days, with at least one as morning 
sample. A sterile universal container 
that is leak-proof is required. Patient is 
instructed to cough out deeply from the 
chest. Saliva is unacceptable. A good 
sputum is thick and purulent. 
Specimen is transported immediately 
to the laboratory in a sealed plastic 
bag.  Transport within 2 hours or 
refrigerate if delay is expected .For 
gastric aspirate, a calculated amount 
of Na2CO3 is added if delay for more 
than 2hours is anticipated. Blood and 
CSF are not to be refrigerated. 
 
Tissues and Body fluids:  
Generally tissue specimens are 
collected by biopsy and body fluid by 
invasive techniques. Tissue specimen 
and needle biopsy material should be 
placed in a small quantity of broth such 
as Middlebrook 7H9 or 7H11 as a 
holding medium and sent to the 
medical microbiology and or 
histopathology laboratory for analysis  
 
Stool:  
Stool specimen may be valuable in 
patients with AIDS, as the 
concentration of mycobacteria 
especially Mycobacteria avium 
intercellularis (MAI) may be sufficiently 
high in the lower intestinal tract to be 
recovered in culture7 
 
Urine:  
Urine specimen may be useful in the 
diagnosis of renal tuberculosis. At 
least three early morning urine 
specimens should be collected on 
successive 24-hour periods to 




Generally, Mycobacterium tuberculosis 
is highly hazardous,stringent safety 
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control standards conforming to the 
Biosafety Level 3 (BSL 3) with a 
Biosafety  Cabinet 2(BSC 2) and 
possibly a dedicated laboratory is 
required for specimen processing5. 
 
1) Microscopy  
This is by far the most widely applied 
diagnostic technique for tuberculosis. It 
is a key test in both diagnostic and 
establishing infectiousness. In most 
resource poor setting, it is the only 
available option. Microscopy can be 
carried out on virtually all clinical 
specimens and requires a simple 
microscope or fluorescent type and 
few reagents8. Microscopy is usually 
the first line test performed on 
specimen. It can be simple microscopy 
using Ziehl- Neelson Staining 
technique or fluorescent microscopy 
using fluorochrome such as auramine 
phenol to enhance visualization. 
Turnaround time is less than   2 hours. 
Advantages of Microscopy: It is 
cheap, rapid and specific. 
Disadvantages of Microscopy: It is 
subjective, less sensitive-about 30-
70% which requires at least 5000-
10,000 AFB per ml of sputum for 
positive result8. Requires 3 sputa and 
is labour intensive. Fluorescent 
microscopy is more sensitive than 
simple microscopy9. The requirement 
for a fluorescent microscope makes it 
prohibitive. Concentration of specimen 
by centrifugation can increase 
sensitivity for non sputum specimen. 
False  Positive: The following if 
present  in  a specimen  can result in a 
false positive result: Norcadia spp, 
Gordonia spp., Tsukamurella spp. 
Legionella micdadei, bacteria 
endospores, Rhodococcus spp  
(sputum),  M. Gastri (Gastric aspirate), 
M. Smegmatis (Urine),M. Gordonae 
(Water Contamination) , artefactual  - 
scratch on the slide.  
Determination of infectiousness in a 
patient with pulmonary tuberculosis  
  
If sputum sample from a previously 
positive patient are negative on 3 
consecutive occasions over 14 days or 
a duration proportionate to the 
effectiveness of the drug treatment 
Patient can be assumed to be non 
infectious by the respiratory route. 
  
3) Culture   
  
This is the gold standard for the 
laboratory diagnosis of tuberculosis. A 
definitive diagnosis of TB requires 
identification of M. tuberculosis from a 
specimen    
Indications for culture: Confirmation 
of Microscopy when uncertain, 
treatment failure, relapse,monitoring of 
Multidrug Resistance (MDR), 
identification of  mycobacterium  
variants  e.g M. boris for 
epidemiological purposes and for 
antimicrobial sensitivity testing. It is 
more sensitive than microscopy – able 
to detect 10 – 100 viable organism per 
ml of specimen8. Before culture, 
sputum require decontamination and 
digestion with 2-4% NaOH- NALC 
solution (N-acetyl, L-cystein). 
Decontamination kills all the normal 
flora of the respiratory tract capable of 
overgrowing in the culture media. 
Digestion is to dissolve mucin and 
other organic component of sputum 
that may wall off the bacilli from 
accessing the nutrient of the media.  
Specimen from sterile sites does not 
require decontamination. 
Concentration by centrifugation is 
required for such specimen before 
culture.  
Media- The common media for the 
culture of mycobacterium tuberculosis 
can be classified into three categories: 
(a) Egg-based media such as 
Lowenstein – Jensen (LJ) medium. 
Duration of culture is 2-6 weeks.  
Benin Journal of Postgraduate Medicine            E. Ogbaini-Emovon 
 
 82  
 
(b) Agar- based media such as 
Middlebrook 7H10 and 7H11.These 
requires about 3-4 week.   
(c) Liquid Media such as Middlebrook 
7H12 and 7H13.These can yield result 
within few days. 
Advantages of culture: Very 
sensitive, can be used for drug 
sensitivity testing, and for 
characterization of species. 
Limitations of culture: Requires 
characterization for species 
identification, very slow-takes some 
week 
 
BACTEK RAPID RADIOMETRIC 
CULTURE SYSTEM 
In 1980, Becton Dickson introduced 
the BACTEC 460 TB Radiometric 
System. This uses liquid media, Middle 
brook 7H12 or 7H13 which contain 
14C – labelled palmitic acid. Growing 
mycobacteria utilizes the acid 
releasing radioactive CO2 which is 
measured by BACTEC instrument 
which indicate it as “growth index”5.
    
Advantages: BACTEC method can be 
read less than 7 days of incubation, 
averages 9-14 days. There is also an 
increase in the yield of positive 
cultures from clinical specimens 
compared with conventional solid 
media10. It can be adapted for 
antimicrobial sensitivity testing11.  
Limitations: It cannot be used for 
colonial morphology in organism 
identification, cost of instrumentation 
and the need for disposal of 
radioactive material 
BACTEK MYCOBACTERIA 
GROWTH INDEX TUBE (MGIT) 
   
The MGIT is a nonradiometric, 
flourescence, manual or automated 
system for the rapid detection of 
mycobacterium species from various 
sites of the body. It  consist of a glass 
tube with modified 7H12 broth base, 
enriched with basic nutrients for 
growth of mycobacteria and a mixture  
of antibiotics to inhibit the growth of 
contaminating bacteria. A flourescent 
compound is embedded at the bottom 
of the tube. The flourescent compound 
does not flourence in the presence of 
oxygen, but following depletion of 
oxygen as a result of mycobacteria 
growth there is flourescence which can 
be detected visually under ultraviolet 
light. In the automated version (MGIT 
960 system), flourescence is detected 
by a sensor. The system holds 960 





The recovery of mycobacterium from 
peripheral blood and bone marrow 
samples may be improved by 
releasing the intracellular 
mycobacterial cells into the blood 
culture broth, increasing the rate and 
reducing the time of recovery. In the 
lysis- centrifugation blood culture 
method, blood is put into a tube 
containing an anticoagulant and a 
lysing agent to effect rupture of both 
erythrocytes and neutrophils. 
Following centrifugation of the tube, 
the sediment is inoculated into the 
appropriate culture media. This 
method has increased both the yield 
and shortened the time of recovery of 
mycobacteria from blood cultures12,13.  
PHAGE AMPLIFICATION 
TECHNIQUE (PAT)    
    
This is a bacteriophage – based test to 
detect M. tuberculosis in sputum. 
Patient sputum is mixed with a reagent 
which contains 
mycobacteriophage.The 
bacteriophage infect the 
mycobacterium tuberculosis in the 
sputum and multiply within it. A 
virucide is added which destroys any 
mycobacteriophage that remains 
outside the tubercle bacilli. The 
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bacteriophages after multiplication lyse 
the mycobacterium cells and are 
released. Rapid (overnight) growing 
non-pathogenic mycobacteria (sensor 
cells) which can also be infected by 
the phage are added and the sample 
is incorporated in an agar mixture, 
plated and incubated overnight at 
370C. The phage replicate, infect and 
lyse the sensor cells leaving zones of 
clearing (holes) in the agar. These 
areas of clearing indicates that the 
patient sputum contain viable M. 
tuberculosis.  
Advantages of PAT: It is fast with a 
turnaround time of 2 days. Cheap and 
requires few equipments. Sensitive– 
can detect as low as 100 tubercles per 
ml of sputum5. It can be adapted for 
sensitivity testing. 
Limitations of PAT: Applicable to 
sputum specimen only and technically 
demanding. 
 
4) IMMUNOLOGICAL METHODS 
Immunological tests are of limited 
application due to cross reactivity and 
poor sensitivity Examples are the 
Myco Dot antibody test,tuberculin skin 
test and the interferon gamma assay. 
Myco Dot Antibody Test: 
It uses purified lipoarabinomannam as 
antigen. Lipoarabinomannan is a 
glycolipid found in the cell wall of 
mycobacteria species.  In this 
approach, the antibody produced in 
response to the mycobacterium 
infection is detected in the patient 
serum by immunoassay. 
Advantages: Very quick, as fast as 20 
minutes and easy to perform. 
Limitations: Sensitivity is low, can 
only detect high levels of antibody as 
found in active diseases. It does not 
rule out TB in patients with poor 
antibody response as in HIV and 
malnutrition. Not specific due to cross 
reactivity with other species of 
mycobacteria in the environment such 
as the Non-Tuberculous 
Mycobacterium (NTM) which the 
individual is exposed to. 
 
TUBERCULIN SKIN TEST 
(MANTOUX TEST)   
The tuberculin test such as mantoux 
test, is a diagnostic tool for 
tuberculosis. It is clinically used as a 
screening test. Nearly 100 years old 
and still the standard of practice in the 
United State in the diagnosis of latent 
TB infection. In this test, a standard 
dose of 5 tuberculin units (0.1 ml of a 
Purified Protein Derivative (PPD) is 
injected intradermally and read 48-
72hrs later. A person who has been 
exposed to the bacteria is expected to 
mount an immune response in the skin 
containing the bacteria protein 
(PPD).The reaction is read by 
measuring the diameter of induration 
(palpable raised hardened area across 
the forearm) in millimeters. Erythema 
(redness) should not be measured. If a 
person has had a history of a positive 
tuberculin test, another test is not 
needed. But if negative, another test 
may be needed. 
Interpretation: The result of this test 
must be interpreted carefully. The 
person’s medical risk factors 
determine at which increment (5mm, 
10mm or 15mm) of induration the 
result is considered positive. A positive 
result indicates TB exposure. 
CDC CLASSIFICATION OF 
TUBERCULIN TEST 
The Centre for Disease Control USA 
bases interpretations on individual 
medical risk factors as follows; 
5mm or more :– Positive for the 
following categories of individual; HIV 
positive patient, recent contact of TB 
case, Patient with nodular or fibrotic 
changes on CXR – evidence of old 
healed TB, patient with organ 
transplant with Immuno-compromise. 
10mm or more: positive for recent 
arrivals (< 5yrs) from high prevalent 
countries, injection drug users, 
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residents and employee of high risk 
settings eg Mycobacteriology 
laboratory personnel, children < 4 
years or adolescent exposed to adult 
in high risk category. 
15mm or more: Positive for person 
with no known risk factor for TB 
 False Positive Results: This may be 
observed in the following 
circumstances; infection by non-
tuberculous mycobacteria (NTM).e.g 
mycobacterium avium intercellularis 
(MAI), from the enviroment, water and 
food, especially in 
immunocompromised patients. 
Previous administration of BCG 
vaccine. This may result in false 
positive results for many years 
afterward14. 
False Negative Results: This may 
result from conditions such as anergy 
which is the lack of the body’s defence 
mechanisms when it comes into 
contact with foreign substances. eg 
AIDS and also in overwhelming TB 
when the immune response has 
waned considerably. 
  
BCG AND TUBERCULIN TEST  
There is disagreement on the use of 
tuberculin   test on people who have 
been immunized with BCG. The US 
recommendation is that previous BCG 
should be ignored, while in the UK, the 
recommendation is that interferon tests 
should be used to help interpret 
positive tuberculin test. The US 
approach is likely to lead to more false 
positive and more unnecessary 
treatment with potentially toxic drugs.  
 
INTERFERON-GAMMA RELEASE 
ASSAYS (IGRA)    
  
Because of the difficulties with the 
tuberculin test interpretation, the 
interferon-gamma assay test was 
developed. This test is used in all 
circumstances in which tuberculin test 
is currently being used such as contact 
investigations, evaluation of recent 
immigrants who have had BCG 
vaccination, TB screening of health 
care workers etc. Two available 
formats of the interferon-gamma 
release assays are; the Quantiferon-
TB Gold and T Spot-TB test. The 
IGRA assay is based on the ability of 
the Mycobacterium tuberculosis 
antigens, which includes the Early 
Secretory Antigen Target 6 (ESAT-6) 
and Culture Filtrate Protein 10 (CFP-
10) to stimulate host production of 
interferon –gamma.  Because these 
antigens are not present in NTM or in 
BCG vaccine, these tests can 
distinguish latent tuberculosis infection 
from BCG immunization. The 
Quantiferon- TB Gold was approved 
by the US Food and Drug 
Administration (FDA) in 2005. This is a 
whole blood test. Blood samples are 
mixed with synthetic peptides of 
ESAT-6 and CFP-10 and incubated for 
16-24 hrs, the amount of interferon-
gamma released by the lymphocytes is 
detected by enzyme immunoassay. 
The T Spot-TB test uses a different 
method of detecting interferon-gamma 
from peripheral mononuclear cells. In 
T Spot-TB assay, T-cells releasing 
interferon-gamma to ESAT-6 and 
CFP-10 are detected and quantified as 
spot –forming cells. 
Numerous studies that have been 
conducted throughout the world using 
these methods show higher specificity 
and better correlation with exposure to 
M. tuberculosis15-19. However, clinical 
evaluation and additional tests such as 
chest radiograph, sputum smear and 
culture are required to confirm the 
diagnosis of latent TB infection or TB 
disease. 
Advantages: Requires a single visit to 
draw a blood sample and result 
available within 24hrs.It does not boost 
immune response measured by 
subsequent tests which can happen 
with tuberculin skin test. Not subject to 
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readers bias as in tuberculin skin test 
and not affected by prior BCG 
vaccination20. 
Disadvantages: Blood must be 
processed within 12hrs while WBC are 
still viable. There are limited data on 
use in children younger 17 yrs of age 
and immunocompromised patients e.g 
HIV/AIDS, diabetics, treatment with 
immunosuppresive drugs In the 
diagnosis of active TB, the interferon 
gamma release assays have reduced 
sensitivity due to their ability to detect 
latent TB20. 
Presently a version of Quantiferon - TB 
Gold test called Quantiferon-TB Gold 
In-Tube is now available in Europe, 
which can provide direct antigen 
stimulation in the blood-drawing tubes 
and eliminate the maximum 12-hours 
processing requirement21. 
In general the adoption of these tests 
(IGRA), requires a dramatic shift, as 
the diagnosis of TB infection will be 
made in the laboratory instead of the 
clinic. This is a welcome shift in that 
laboratories are more likely to give 
reliable results because of routine 
quality assurance and proficiency 
testing, something that is not possible 
in all clinical settings in a given locale. 
.  
4) MOLECULAR DIAGNOSTIC 
TECHNIQUES (DNA PROBE AND 
PCR)  
Molecular techniques are aimed at the 
nucleic acid of the mycobacterium as 
the analyte.They are the newest 
diagnostic techniques in the 
armamentarium of clinical microbiology 
laboratory and include techniques 
such as  DNA Probe and the 
Polymerase Chain 
Reaction(PCR)22.Ribosomal rRNA is 
useful genetic target for the 
identification of organisms, since it  
often contain signature sequences and 
is present in the cells and culture in 
high quantity secondary to the growth 
of the bacillus (biologic amplification).  
There are various applications of these 
in the detection and identification of 
Mycobacterium tuberculosis23-26. 
These includes; culture confirmation of 
isolates recovered from clinical 
specimens using DNA probes, the 
identification of Mycobacteria through 
DNA  sequencing, direct detection of 
M. tuberculosis  in clinical specimen 
using nucleic acid amplification assays 
e.g Polymerase Chain Reaction (PCR) 
and DNA  fingerprinting and strain- 
typing of Mycobacterium species. The 
concern is that these state-of-the art 
technologies are complex and 
expensive and are not affordable in 
developing countries where 95% of the 
global burden of tuberculosis is 
located.  
Advantages of Molecular 
Techniques: They are rapid (within 
few hours), highly sensitive and 
specific.  Disadvantages of 
Molecular Techniques: Expensive, 
requires expertise and may not 
differentiate active infection as DNA 
from a dead organism during antibiotic 
treatment can be detected and 
amplified by PCR. 
 
SPECIATION AND STRAIN-TYPING 
This is important for purposes of 
epidemiologic studies and may help to 
establish new infections or mutant 
strains as well as determination of 
sources of infection e.g 
Mycobacterium bovis from infected 
milk source, patient with multidrug 
resistant TB (MDR-TB) etc. Strain-
typing can expand our understanding 
of transmission, including in settings 
outside the traditional concentric-circle 
approach, where TB transmission can 
occur. Once an isolate has been 
recovered in the mycobacteriology 
laboratory, a Ziehl- Neelsen staining is 
performed to confirm that it is an acid-
fast bacillus. In order to speciate, 
phenotypic characteristics such as 
colony morphology, growth rate, 
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optimum growth temperature and 
photoreactivity are presumptively 
applied. More definitive test include 




These are batteries of tests that are 
based on the enzymatic and metabolic 
characteristics of the bacteria in terms 
of nutrient requirements and utilization 
as well as their metabolic products. 
For example MTB complex can be 
differentiated from the NTM by the 
following characteristics; buff colony 
on solid media, slow growth rate, Lack 
of pigment, reduction of nitrate, 
production of niacin and a positive 
catalase  test which is  inactivated at 
680 C. 
   
CHROMATOGRAPHY  
This technique is based on the 
difference in length of mycolic acid 
residue on the cell wall of different 
species. It is used for speciation 
following isolation by cultural 
techniques. This technique is used in 
reference laboratories for 
epidemiologic studies. 
Chromatographic techniques have 
changed as technology has evolved. 
Earlier methods such as column 
chromatography and thin layer 
chromatography have been replaced 
by gas chromatography and most 
recently by high pressure liquid 
chromatography 
(HPLC).Chromatography is rapid, a 
total time of 2 hours is required. It is 
highly reproducible, and as little as a 
loopful of organism is required27. The 
draw back of this technique is the 
initial cost of equipment which is high. 
The use of negative-ion mass 
spectrometry to detect tuberculostearic 
acid in clinical specimens is also 
gaining ground and hold promise for 
the rapid detection of mycobacteria28.  
 
GENOTYPING 
This is an essential tool in the 
laboratory for TB epidemiology. 
Genotyping relies on molecular 
techniques based on PCR. New PCR-
based genotyping methods include 
Spacer Oligonucleotide Typing 
(Spoligotyping) and Mycobacterial 
Interspersed Repetitive Unit (MIRU) 
typing. Spoligotyping is based on 
differences between strains in the 
spacer sequences in the direct repeat 
locus of the M. tuberculosis genome. 
MIRU is based on variable numbers of 
tandem repeat at 12 loci in the 
genome of M. tuberculosis29. These 
genotyping techniques can provide 
typing information from culture within a 
month from the time the specimen is 
collected from patient. Genotyping is 
useful in answering specific question 
related to suspected outbreak of TB in 
institutions such as hospitals schools 
and prisons. PCR based strain-typing 
requires only a small cell mass and 
yield numerical results that can be 
compared easily either within a 
laboratory or between laboratories to 
determine whether two strains are the 
same. 
When used together for strain typing, 
spoligotyping and MIRU provide a 
powerful combination of tools that can 
discriminate strains which are not part 
of the chain of transmission21. Rarely, 
however, unrelated strain could have 
the same spoligotyping and MIRU 
number21. This limitation has given rise 
to DNA fingerprinting 
 
DNA fingerprinting  
DNA fingerprinting based on restriction 
fragment length polymorphism (RFLP) 
is the gold standard for strain- typing in 
mycobacteriology. The insertion 
sequence IS6110 was specifically 
identified as the target of DNA probe to 
be used in fingerprint analysis30,31. It 
requires a week for the assay to be 
performed and results evaluated. The 
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limitations of genotyping by RFLP is 
that a large cell mass is required and 
the results are band-pattern, thereby 
difficult to convert into digital format 
making comparison difficult. It is 
however available only in regional 
laboratories and not yet a routine 
technique. 
 
DRUG SUSCEPTIBILITY AND 
RESISTANCE TESTING  
The need for prompt and accurate 
antimycobacterial susceptibility testing 
for Mycobacteria tuberculosis has 
become a necessity, since the 
emergence of Multi Drug Resistant 




These methods include proportional 
methods, the radiometric method, and 
modified phage amplification 
technique. In the proportional method, 
the mycobacteria isolate is incubated 
on two similar agar slope of 
Middlebrook 7H10. One of these 
contain a recommended concentration 
of antimycobacteria and the other free 
of the drug. This will require extra 2 
weeks or more from the isolation of the 
organism. Interpretation is based on a 
standard proportion method which is 
the number of organisms resistant to 
each drug concentration as a 
percentage of the number of organism 
growing on the drug free media. Drug 
routinely tested are streptomycin, 
isoniazid, rifampicin and ethambutol. 
In the BACTEC Radiometric method, a 
standardized innoculum is inoculated 
into a drug free and a drug containing 
vial. The amounts and rates of CO2 
produced in the absence and presence 
of the drug are compared to determine 
susceptibility or resistance. The 
BACTEC radiometric method would 
require extra 2 to 3 weeks from 
isolation. The BACTEK MGIT 960 and 
BACTEK 460 are currently the only 
methods currently cleared for use in 
the USA11. Susceptibility tests should 
be carried out in all initial isolates of M 
tuberculosis and on isolates from 
patients who remain culture- positive 
after 3 months or demonstrate clinical 
evidence of therapeutic failure11.   
In the modified phage amplification 
technique, the antimicrobial tested for 
is incorporated into the medium 
inoculated with the mycobacterium 
isolate, while the second medium is 
similarly inoculated without the drug. 
Growth comparison is made after 
incubation for 2 days. 
 
GENOTYPIC METHODS 
These entail molecular techniques 
aimed at detecting genes that code for 
resistance characteristics. Example 
includes; DNA probe and DNA 
sequencing of M. tuberculosis gene 
such as catalase (katG) or RNA 
polymerase (rpoB). Mutations in these 
genes have been associated with 
resistance to isoniazid and rifampicin 
respectively32,33, the most common 
drugs used to treat TB. The use of 
Molecular beacons in a real- time PCR 
reaction, first described in 2004, can 
differentiate between the presence of 
the wild- type sequence associated 
with drug susceptibility or a mutated 
sequence associated with drug 
resistance34. Genotypic methods are 
not routinely used in the 
mycobacterium laboratory; they are 
essentially for research purposes 
 
THE FUTURE OF TB DIAGNOSTICS 
The rapid technological evolution in 
the laboratory diagnosis of TB, 
especially in the application of 
molecular biology has diminished the 
time required for identification and 
susceptibility testing and may eliminate 
the need for lengthy culture and 
protracted biochemical methods. With 
continuous effort at increasing their 
reproducibility, ease of performance 
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and cost containment, it is hoped that 
they will soon evolve from reference 
laboratories into clinical diagnostic 
laboratories. For now, there is need for 
integration of services provided by 
public and private laboratories with 
tuberculosis-control programmes to 
provide an effective system for 
diagnosis, treatment and control of 
TB35. In instances where some of the 
newer molecular methods are not 
available, or are not cost effective, as 
in developing countries, a system must 
be developed so that testing can be 
referred, in a timely manner to a 
reference laboratory. A critical 
component of such a system will be to 
assure that results are sent to the 
appropriate TB-control programmes, 
as well as to the health-care provider. 
Development and promotion of this 
integrated system is a challenge and 
responsibility of all mycobacteriology 
staff and public health experts. 
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